KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
KNTE
Delisted
KNTE was delisted on the 2nd of April, 2024.
71 hedge funds and large institutions have $750M invested in Kinnate Biopharma Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 25 increasing their positions, 14 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
17% less capital invested
Capital invested by funds: $905M → $750M (-$155M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $23K
Holders
71
Holding in Top 10
5
Calls
–
Puts
$23K
Top Buyers
| 1 | +$11.9M | |
| 2 | +$3.06M | |
| 3 | +$1.08M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$999K |
| 5 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$967K |
Top Sellers
| 1 | -$12.4M | |
| 2 | -$6.51M | |
| 3 | -$2.73M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$2.17M |
| 5 |
DM
Deerfield Management
New York
|
-$761K |